IQVIA SmartSolve® Risk Management streamlines product- and process-based risk assessments with guided, methodology-driven workflows for FMEA and PHA. The solution helps medical device and IVD manufacturers improve consistency and traceability across risk identification, evaluation, mitigation, acceptance and reporting, while supporting ISO 14971:2019-based risk management, audit readiness and regulatory compliance.
You may also be interested in
See how IQVIA Vigilance Detect delivers measurable GenAI-powered results in adverse event detection—setting a new standard for pharmacovigilance.
Related solutions
Outdated compliance practices aren't viable amid evolving market and regulatory changes. IQVIA’s award-winning, end-to-end quality management system streamlines the product value chain, accelerates market entry, safeguards companies and patient safety, and meets complex regulatory demands.
Discover how an end-to-end eQMS solution empowers QARA professionals to remain agile, well-informed, and proactive in ensuring the safety and efficacy of medical devices.
Replace spreadsheets and disconnected tools with a single eQMS for deviations, audits, CAPAs, and approvals. SmartSolve® helps pharma teams maintain control, reduce compliance risk, and support regulatory readiness.
.svg){kind=icon}
